Regen BioPharma Issues $125,000 in 10% Unsecured Debt

• Regen BioPharma issued a $125,000, 10% unsecured promissory note with an 18-month term to Coventry Enterprises on October 27, 2026.
• Coventry retained $12,500 as an original issue discount; proceeds repaid $71,557 of existing convertible debt and accrued interest.
• Principal and $12,500 of guaranteed interest are payable in eight monthly installments of $17,187.50, beginning six months after funding.
• Upon default, Coventry may convert the note into common shares at 90% of the lowest trading price over the preceding 20 trading days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regen BioPharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-049508), on November 02, 2026, and is solely responsible for the information contained therein.